Ignite Creation Date:
2024-07-17 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467617
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-13
Brief Title:
Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC
Sponsor:
Organization:
Beijing Chest Hospital Capital Medical University